SCHEMBL17057993

SCHEMBL17057993

O=c1c(OC2CCC(F)C2)c(N2CCN(SCc3ccccc3)CC2)cnn1-c1cc(F)cc(F)c1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RAB9A P51151 5/20 0.34
▸ SMN1; SMN2 Q16637 5/20 0.34
▸ NPC1 O15118 4/20 0.34
▸ SLC2A1 P11166 2/20 0.34
▸ SLC2A3 P11169 2/20 0.34
▸ ALDH1A1 P00352 8/20 0.33
▸ MAPT P10636 3/20 0.32
▸ LMNA P02545 3/20 0.32
▸ POLB P06746 2/20 0.32
▸ PPARG P37231 2/20 0.32
▸ NCOA2 Q15596 2/20 0.32
▸ NCOA1 Q15788 2/20 0.32
▸ KMT2A Q03164 1/20 0.32
▸ NPSR1 Q6W5P4 2/20 0.32
▸ HTT P42858 1/20 0.31
▸ MCL1 Q07820 1/20 0.31
▸ DCTPP1 Q9H773 2/20 0.31
▸ RXFP1 Q9HBX9 1/20 0.31
▸ CYP3A4 P08684 1/20 0.31
▸ CYP2C19 P33261 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17057951 0.95 SLC2A1 (0.34) RAB9ASMN1; SMN2NPC1SLC2A1SLC2A3
SCHEMBL17057800 0.94 SLC2A1 (0.31) SLC2A1SLC2A3
SCHEMBL17057794 0.89 SLC2A1 (0.32) SLC2A1SLC2A3
SCHEMBL17058188 0.89 NPC1 (0.39) RAB9ASMN1; SMN2NPC1SLC2A1SLC2A3
SCHEMBL17058350 0.88 SLC2A1 (0.32) RAB9ASMN1; SMN2NPC1SLC2A1SLC2A3
SCHEMBL17058277 0.88 SLC2A1 (0.31) SLC2A1SLC2A3
SCHEMBL17058338 0.85 SLC2A1 (0.32) SLC2A1SLC2A3
SCHEMBL11944798 0.85 MAPT (0.42) ALDH1A1MAPTLMNAPOLBPPARG
SCHEMBL17057810 0.85 SLC2A1 (0.33) RAB9ASMN1; SMN2NPC1SLC2A1SLC2A3
SCHEMBL17058314 0.84 SLC2A1 (0.30) SLC2A1SLC2A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2137179-B1 PYRIDAZINONE DERIVATIVES USEFUL AS GLUCAN SYNTHASE INHIBITORS MERCK SHARP & DOHME (US) 2015-09-02 — — EP disclosed
Send feedback